Skip to main content

Clinical trial BSMO 2014 01

A prospective, Belgian multi-center, single-arm, phase II study of neoadjuvant weekly paclitaxel and carboplatin followed by dose dense epirubicin and cyclophosphamide in stage II and III triple negative breast cancer

Organ sein
Trial status Trial closed for recruitment
Trial type
Interventionnal with IMP
Phase Trial phase 2
Academic trial Oui
Sponsor UZ-Brussel
EudraCT Identifier 2014-003723-21
Inclusion criteria TNBC
Last update